Martin Pergler shares an article that explains why it’s time for governments to start properly risk managing their COVID-19 crisis response. Colleen M. Flood FRSC, FCAHS, is the Director of the Centre for Health Law, Policy and Ethics and University Research Chair at the University of Ottawa. Martin Pergler is Principal at Balanced Risk Strategies, an international consultancy based in Ottawa specializing in risk management and decisions under uncertainty. Let’s review the past seven weeks, since the Omicron variant was…

  Forbes published an article from Stephen Wunker that explores how we can leverage lessons learned from COVID-19 to develop, improve, and use scenario planning.  Leading up to 2020, executives were already grappling with rising disruptive technologies, changing business models, and rivals emerging from unexpected places. Throw in a global pandemic, and the future seems about as predictable as a game of Rock, Paper, Scissors with a hundred hands. While some were poised to respond to the turbulence that coronavirus…

Umbrex is pleased to welcome Nicholas Gertler with Galen/Atlantica.  Nicholas is co-founder of Galen/Atlantica, a boutique agency that shapes markets and co-creates health. He works with the global pharmaceutical industry across the medicines lifecycle on issues of regulation, access, medical and policy, and with medical foundations addressing complex multi-stakeholder issues. An enduring passion is solving antimicrobial resistance, while a new focus is the proper application of artificial intelligence to medical decision-making. He has co-led a dozen initiatives bringing together senior…

Umbrex is pleased to welcome Yevgeniy Rikhterman.  Yevgeniy Rikhterman spent three years as the Director of Strategy at Herff Jones, a PE owned CPG company. Yevgeniy has experience in creating strategic plans, as well as an evergreen strategic planning processes. Yevgeniy led the strategic planned that helped to maximize the value of Herff Jones during a critical PE transaction. He also led the corporate development, and M&A aspect, and as such has specific experiences that is applicable to mid-size companies…

Umbrex is pleased to welcome Tushar Srivastava. Tushar is an independent strategy consultant who started his consulting career at McKinsey where he spent more than 3.5 years working as a generalist, eventually developing a spike in healthcare and life sciences. He has spent more than 3 years working as an Independent with multiple projects in pharma, life sciences, medical technology and healthcare. Functionally, he is comfortable working on strategy initiatives across R&D, marketing, operations, technology, and pre-sales. He is open…